CITIUS PHARMACT Balance Sheet - Quarterly (NASDAQ:CTXR)

Add to My Stocks
$1.35 $0.03 (2.17%) CTXR stock closing price Sep 18, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our CITIUS PHARMACT stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the CITIUS PHARMACT stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. CITIUS PHARMACT had a long term debt of $- at the end of 2018 Q3. To understand the debt servicing capacity of the company, one needs to look at CITIUS PHARMACT operating cash flow and CITIUS PHARMACT revenue also. CITIUS PHARMACT debt to equity ratio is .

View and download CITIUS PHARMACT quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets19.4M19.4M19.4M19.4M19.4M19.4M19.4M19.4M19.4M19.4M
Total Assets
Notes Payable----------
Accounts Payable-1.4M--1.97M1.86M----
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses1.11M-1.86M1.66M1.97M3M2.9M1.89M1.38M1.64M
Income Taxes Payable----------
Other Current Liabilities-------1.7M2.98M1.57M
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus59.04M58.88M56.81M49.66M36.26M36.17M34.6M34.02M32.83M31.48M
Retained Earnings-37.41M-35.38M-30.96M-27.72M-24.67M-22.25M-19.51M-17.33M-14.74M-11.13M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity21.64M23.5M25.85M21.94M11.59M13.99M15.16M16.76M18.16M20.42M
Total Liabilities & Shareholders Equity23.83M26.06M28.47M24.41M21.56M21.33M21.48M21.95M23.01M24.77M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at CITIUS PHARMACT historical stock prices and the current CITIUS PHARMACT stock price can tell you how the stock price has moved, whereas the CITIUS PHARMACT PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like CITIUS PHARMACT owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for CTXR stock as of 2018 Q3 is $23.83M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for CITIUS PHARMACT is $2.19M. Shareholders equity comes under liabilities as it is money the company owes the holders of CTXR stock.

CITIUS PHARMACT Balance Sheet - Key Ratios